Ketogenic (modified Atkins) diet for hypothalamic tumor–related central obesity
Official title: Single-arm, Open-label, Single-center, Non-profit Interventional Clinical Trial on the Effects of the Ketogenic Diet in Patients With Brain Tumors and Central Obesity
Run by Meyer Children's Hospital IRCCS · NCT07396896 · Data updated 2026-11-12
This trial will try a modified Atkins ketogenic diet to help children and young adults with hypothalamic-chiasmatic tumors lose excess weight.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 7 Years to 30 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Meyer Children's Hospital IRCCS Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Florence, Florence) |
| Status | Recruiting |
| Started | May 8, 2025 |
| Main results expected | April 2028 |
| Study ends | April 2028 |
| Registry record updated | February 9, 2026 |
| Trial ID | NCT07396896 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children and young adults aged 7–30 with a confirmed hypothalamic-chiasmatic tumor, BMI above the 97th percentile (after age 5), and adequate performance status who can follow a ketogenic diet are ideal candidates.
✕Probably not a fit
Patients with inherited fatty-acid oxidation or related metabolic disorders, those unable to adhere to a ketogenic eating plan, or whose obesity is not driven by hypothalamic injury are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional, single-center protocol enrolls patients aged 7–30 who have hypothalamic-chiasmatic tumors and severe hypothalamic obesity that is refractory to medical therapy. Participants will follow a modified Atkins ketogenic diet with regular clinical monitoring, metabolic laboratory testing, and safety checks, and individuals with inherited fatty-acid oxidation or related metabolic enzyme deficiencies are excluded. The research is conducted at Meyer Children's Hospital IRCCS in Florence and requires informed consent from patients and guardians for minors. Primary outcomes will focus on changes in weight/BMI and metabolic/endocrine markers, along with measures of tolerability and adherence.
Why it matters
Potential benefit: If successful, the diet could reduce excessive weight and improve metabolic health and quality of life for patients with hypothalamic obesity.
How similar studies have gone: Ketogenic diets are well established for pediatric drug-resistant epilepsy, but their specific use for hypothalamic obesity is novel and supported mainly by small case series and limited pilot data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Diagnosis of hypothalamic-chiasmatic tumour according to the WHO 2021 classification 2. Diagnosis of hypothalamic obesity: after 5 years of age, BMI \>97th percentile in the WHO 2007 curves 3. Males and females aged between 7 and 30 years 4. Performance status: Lansky score \> 40 for patients aged \< 18 years and Karnofsky score \> 40 for patients aged between 18 and 30 years 5. Signature of informed consent to participate in the study 6. Signature of consent by the minor patient to participate in the study (7-13 years and 14-17 years). Exclusion Criteria: 1\. Deficiencies of: * Primary carnitine * Carnitine palmitoyltransferase 2 (CPT 2) * Carnitine acylcarnitine translocase (CACT) * Beta-oxidation * Medium-chain acyl-CoA dehydrogenase (MCAD) * long-chain acyl-CoA dehydrogenase (LCAD) * short-chain acyl-CoA dehydrogenase (SCAD) * porphyria * pyruvate carboxylase * long-chain 3-hydroxyacyl-CoA dehydrogenase.
Where it's running
-
Meyer Children's Hospital IRCCS
Florence, Florence, Italy Recruiting
Study contacts
- Study coordinator: Iacopo Sardi
- Email: iacopo.sardi@meyer.it
- Phone: 0555662631
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Optimized Flow for Obese Patients Undergoing Heart Surgery
In this study, researchers will test whether using ideal body weight to set cardiopulmonary bypass flow during heart surgery helps obese adults see fewer transfusions and related complications.
-
External Oblique Intercostal Block With or Without Lidocaine for Pain After Gastric Bypass
This study tests whether adding a lidocaine IV infusion to a bilateral EOIB with low-dose fentanyl helps manage pain during gastric bypass in obese adults.
-
Bariatric Surgery and Gut Microbiota Changes Over Time
This study looks at how gut bacteria and stool metabolites change over 12 months after Roux-en-Y gastric bypass in adults with obesity, compared with those treated with diet alone and healthy-weight individuals.
-
KDS2010 for weight loss in adults with overweight or obesity
This trial will test whether daily KDS2010 helps adults with overweight or obesity lose weight safely compared with a placebo.
-
Using adjustable headrests to improve breathing during painless surgery for overweight patients
This study is testing if using adjustable headrests can help overweight patients breathe better and stay safe during painless surgery.
-
Non-endoscopic test to find Barrett's esophagus in veterans without chronic reflux.
This project will test whether a simple, non-endoscopic swab-like test can find Barrett's esophagus in veterans over 40 who have risk factors for esophageal cancer but no chronic heartburn.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.